MACROGENICS INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($58.5m)
($19.6m) +66.47%
($171.5m) -773.60%
($151.8m) +11.46%
($129.7m) +14.54%
($202.1m) -55.79%
($119.8m) +40.75%
($9.1m) +92.44%
($67.0m) -639.30%
($74.6m) -11.43%
Depreciation, Depletion and Amortization $7.6m $7.2m $8.3m $10.8m $12.0m $11.3m $11.9m $9.6m $7.5m $7.2m $7.1m
Depreciation $6.8m $7.0m $9.2m $12.3m $12.0m $11.3m $11.9m $9.6m $7.5m $7.2m $7.1m
Share-based Payment Arrangement, Noncash Expense $12.2m $14.7m $16.5m $19.6m $20.7m $23.1m $20.4m $18.4m $29.4m $14.3m $12.5m
Payment, Tax Withholding, Share-based Payment Arrangement $39k $40k $260k $0 $2.0m $306k $2.5m $288k
Share-based Payment Arrangement, Expense $12.2m $14.7m $16.5m $19.6m $20.7m $23.1m $20.4m $18.4m $29.4m $14.3m $12.5m
Other Nonoperating Income (Expense) $1.5m $2.5m ($247k) $25.4m $1.3m $680k $1.7m $9.7m $9.4m $6.1m
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $1.5m $10.9m $15.9m ($16.8m) $10.3m ($12.7m) $45.8m ($45.9m) ($6.1m) $9.1m $117k
Increase (Decrease) in Inventories $6.4m ($55k) ($230k) $2.2m $7.9m ($73k)
Increase (Decrease) in Accounts Payable $2.2m ($1.5m) $1.6m $787k $3.7m $7.1m ($10.9m) $1.3m ($1.5m) ($280k) ($2.3m)
Net Cash Provided by (Used in) Operating Activities ($43.7m)
$14.4m +132.98%
($153.2m) -1163.76%
($134.3m) +12.38%
($111.9m) +16.66%
($143.8m) -28.54%
($87.0m) +39.54%
($78.2m) +10.07%
($68.4m) +12.57%
($81.0m) -18.53%
($70.0m) +13.67%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $11.4m $29.4m $25.0m $4.3m $5.9m $6.2m $3.6m $1.8m $3.7m $1.9m ($1.7m)
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $66k $66k $508k $118k ($111k) $57k $10k ($10k)
Unrealized Gain (Loss) on Investments ($77k) $21k $58k $19k ($23k) ($54k) $56k ($1k) $10k $28k
Net Cash Provided by (Used in) Investing Activities ($70.2m) $77.9m $56.6m ($79.4m) ($7.8m) ($36.6m) $70.7m ($80.1m) $149.3m ($114.1m) ($78.7m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $0 $34.2m $103.3m $118.7m $170.5m $117.8m $1.1m $616k $0 $0 $0
Net Cash Provided by (Used in) Financing Activities $1.9m
$35.3m +1806.58%
$105.0m +197.02%
$120.0m +14.27%
$174.3m +45.32%
$122.8m -29.58%
$1.7m -98.65%
$150.4m +8963.35%
$960k -99.36%
$69.5m +7141.04%
$69.6m +0.11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $196.2m $84.1m $211.7m ($93.7m) $54.7m ($57.7m) ($14.6m) ($7.9m) $81.9m ($125.6m) $66.5m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $126.5m $181.1m $123.5m $108.9m $101.0m $182.8m $57.2m $66.5m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from Stock Options Exercised $1.9m $500k $900k $700k $5.3m $5.8m $200k $100k $3.1m $0
Additional Financial Items
General and Administrative Expense $29.8m $32.7m $40.5m $46.1m $42.7m $63.0m $58.9m $52.2m $71.0m $39.2m
Income Tax Expense (Benefit) $0 $0 $0 $0 $0 $0 $0 $0 $944k ($672k)
Interest Expense Nonoperating $8.5m